Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celine Faure

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Asian Journal of Andrology|April 16, 2024
Machine learning approach to assess the association between anthropometric, metabolic, and nutritional status and semen parametersGuillaume Bachelot, Antonin Lamaziere, Sebastien Czernichow, et al.
Antioxidants & Redox Signaling|January 22, 2014
Are superoxide dismutase 2 and nitric oxide synthase polymorphisms associated with idiopathic infertility?Celine Faure, Pauline Leveille, Charlotte Dupont, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|September 3, 2020
Adding Haptic Feedback to Virtual Environments With a Cable-Driven Robot Improves Upper Limb Spatio-Temporal Parameters During a Manual Handling TaskCeline Faure, Alexis Fortin-Cote, Nicolas Robitaille, et al.
Breast (Edinburgh, Scotland)|June 19, 2018
Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumabQuentin Jacquinot, Sophie Paget-Bailly, Pierre Fumoleau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2017
Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non-Small Cell Lung CancerWendy A Cooper, Prudence A Russell, Maya Cherian, et al.
Lancet (London, England)|June 11, 2019
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trialXavier Pivot, Gilles Romieu, Marc Debled, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Asian Journal of Andrology|April 16, 2024
Machine learning approach to assess the association between anthropometric, metabolic, and nutritional status and semen parametersGuillaume Bachelot, Antonin Lamaziere, Sebastien Czernichow, et al.
Antioxidants & Redox Signaling|January 22, 2014
Are superoxide dismutase 2 and nitric oxide synthase polymorphisms associated with idiopathic infertility?Celine Faure, Pauline Leveille, Charlotte Dupont, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|September 3, 2020
Adding Haptic Feedback to Virtual Environments With a Cable-Driven Robot Improves Upper Limb Spatio-Temporal Parameters During a Manual Handling TaskCeline Faure, Alexis Fortin-Cote, Nicolas Robitaille, et al.
Breast (Edinburgh, Scotland)|June 19, 2018
Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumabQuentin Jacquinot, Sophie Paget-Bailly, Pierre Fumoleau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2017
Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non-Small Cell Lung CancerWendy A Cooper, Prudence A Russell, Maya Cherian, et al.
Lancet (London, England)|June 11, 2019
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trialXavier Pivot, Gilles Romieu, Marc Debled, et al.
Pageof 1